Intrinsic Value of S&P & Nasdaq Contact Us

ENDRA Life Sciences Inc. Warrants NDRAW NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
46/100
2/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — NDRAW

ENDRA Life Sciences Inc. Warrants (NDRAW) and trades at $0.03. The 52-week range is 0.01-0.03.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-8.93.

The stock has a beta of 4.23, operates in the Healthcare sector.

Trading Data
Current Price$0.03
52-Week Range0.01-0.03
Volume113.76K
Beta (1Y)4.23
Company
IPO Date2017-06-28
CEONone
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
Income (Latest Year)
EBITDA$-5.61M
Operating Income$-5.76M
Net Income$-7.03M
EPS$-8.93
EPS Diluted$-8.93
Shares Outstanding$787.02K
Balance Sheet (Latest Year)
Total Assets$3.85M
Current Assets$967.97K
Cash & ST Investments$762.37K
Total Liabilities$1.59M
Total Debt$492.35K
Net Debt$-270.01K
Total Equity$2.26M
Debt / Equity0.22
Valuation Ratios
P/E Ratio-0
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message